On July 11, 2019, the U.S. Department of Justice announced that Reckitt Benckiser Group PLC agreed to pay $1.4 billion to resolve possible criminal and civil liability related to allegations... read more
On July 11, 2019, the U.S. Department of Justice announced that Reckitt Benckiser Group PLC agreed to pay $1.4 billion to resolve possible criminal and civil liability related to allegations... read more
Life science investment firm, Medicxi, announced on 7/19/19 that it has closed its Medicxi III fund. This brings the total amount raised by Medicxi in the last three years to over $1 billion. The... read more
4D Pharma Commences Ph 1/II Asthma Trial
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its... read more
Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, announced on 7/16/19... read more
Life science focused Vida Ventures is advancing on its goal of raising $600 million for its second VC fund. According to a recent... read more